Clinical Trial Update: A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes. [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update reporting the completion of a study evaluating ranolazine's effect on postprandial glucagon in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ranexa (ranolazine)

Snippet

Sponsor: Gilead Sciences | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED